Previous 10 | Next 10 |
Eiger BioPharmaceuticals Strengthens Management Team with New Appointments PR Newswire William G. Kachioff appointed as Chief Financial Officer James A. Vollins appointed as General Counsel, Chief Compliance Officer and Corporate Secretary PALO ALTO, Calif. ...
2023-03-17 16:16:22 ET Summary Here's a long list of biopharmas exposed to SVB Financial Group. Many of these deposits will be uninsured. However, since SVB Financial Group was quite solvent otherwise, much of these deposits should be recoverable by these small companies. ...
2023-03-16 16:50:36 ET Eiger BioPharmaceuticals press release ( NASDAQ: EIGR ): Q4 GAAP EPS of -$0.57 misses by $0.03 . Revenue of $2.69M (-19.9% Y/Y) misses by $1.73M . Selling, General and Administrative expenses were $8.3 million and $29.1 million ...
Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update PR Newswire Phase 3 HDV D-LIVR (lonafarnib/ritonavir) Study: Pre-NDA Meeting Planned by End of Q2 Phase 3 HDV LIMT-2 (peginterferon lambda) Study: On T...
Summary December 2022 was one of those months for Eiger to prove the old saying what doesn't kill you, makes you stronger. Its executive shake-up is hard to ignore. New England Journal Of Medicine article put Eiger's COVID-19 strategy in the spotlight. Eiger generates sizable qu...
Eiger BioPharmaceuticals ( NASDAQ: EIGR ) added ~6% pre-market Thursday after announcing that The New England Journal of Medicine published data from the investigator-sponsored Phase 3 TOGETHER Study for its experimental COVID therapy peginterferon lambda. In September, Eiger ...
New England Journal of Medicine Publishes Positive Phase 3 TOGETHER Results with Peginterferon Lambda in COVID-19 PR Newswire - Phase 3 TOGETHER data showed early treatment with a single dose of peginterferon lambda (Lambda) in patients with mild-to-moderate COVID-19 infection...
The new year is rapidly approaching, which means figuring out how to make money in the stock market. One of the asset classes that has continued outperforming broader markets daily has been stocks under $5. Known as penny stocks , these cheap shares are well-known for their short-term yet...
Whether you’re looking for the best penny stocks to buy now or just putting together a watch list, research is the first place to begin. Understanding why specific stocks are moving the way they are can help when applying your trading strategy to the stock market today. That’s b...
President and CEO David A. Cory resigns from the company effective immediately Dr. David Apelian named Interim CEO Eiger BioPharmaceuticals, Inc. (“Eiger” or “the company”) (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the de...
News, Short Squeeze, Breakout and More Instantly...
Eiger BioPharmaceuticals Inc. Company Name:
EIGR Stock Symbol:
NASDAQ Market:
Eiger BioPharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Nikola Corporation (NKLA) rose 6.5% to $0.95 on volume of 182,734,103 shares WiSA Technologies Inc. (WISA) fell 3.3% to $0.0235 on volume of 160,634,740 shares PROSHARES TRUST (SQQQ) rose 4.7% to $11.12 on volume of 151,373,755 shares...
A look at the top 10 most actives in the United States Sunshine Biopharma Inc. (SBFM) rose 76.0% to $0.1065 on volume of 290,483,542 shares CXApp Inc. (CXAI) rose 151.0% to $6.15 on volume of 236,739,031 shares Nikola Corporation (NKLA) fell 1.0% to $1.03 on volume of 123,276,764 shares ...
Announces “Stalking Horse” Agreement for the Sale of Zokinvy ® (lonafarnib) Patient Access to Zokinvy ® to Continue Uninterrupted PALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR) today ...